If all standard treatments for hairy cell leukemia (HCL) have been exhausted, there are still options to consider:
1. Clinical Trials: Researchers are studying new treatments for HCL in clinical trials. These trials can offer access to new therapies that may be more effective than standard treatments. Current treatments Show Full Answer
If all standard treatments for hairy cell leukemia (HCL) have been exhausted, there are still options to consider:
1. Clinical Trials: Researchers are studying new treatments for HCL in clinical trials. These trials can offer access to new therapies that may be more effective than standard treatments. Current treatments being studied include:
- Imbruvica (ibrutinib): Blocks the growth of HCL cells and may treat relapsed leukemia.
- LMB-2: An antibody that targets the CD25 protein on HCL cells.
- BL22: An antibody-toxin combination that can recognize and kill HCL cells.
- Zelboraf (vemurafenib): Targets cells with mutations in the BRAF gene.
2. Community Support: Engaging with support networks like MyLeukemiaTeam can provide emotional support and practical advice from others who understand life with leukemia.
3. Watch and Wait: For some, a "watch and wait" approach may be appropriate, especially if they are not experiencing symptoms. This involves regular monitoring without immediate treatment to avoid side effects.
4. Symptom Management: Focus on managing symptoms and maintaining quality of life through supportive care.
It's important to discuss all available options with your healthcare provider to determine the best course of action based on your specific situation.
July 11, 2024
Continue with Facebook
Sign up with your email
